📣 VC round data is live. Check it out!

Nexalin Technology Valuation Multiples

Discover revenue and EBITDA valuation multiples for Nexalin Technology

Nexalin Technology Overview

About Nexalin Technology

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.


Founded

2010

HQ

United States

Employees

14

Financials (LTM)

Revenue: $320K
Net Income: ($8M)

EV

$10M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nexalin Technology Financials

Nexalin Technology reported last 12-month revenue of $320K.

In the same LTM period, Nexalin Technology generated $253K in gross profit and had net loss of ($8M).


Nexalin Technology P&L

In the most recent fiscal year, Nexalin Technology reported revenue of $302K and EBITDA of ($8M).

Nexalin Technology is unprofitable as of last fiscal year, with gross margin of 80%, EBITDA margin of (2771%), and net margin of (2723%).

See analyst estimates for Nexalin Technology
LTMLast FY202320242025202620272028
Revenue$320K$302K$111K$169K$302K
Gross Profit$253K$240K$85K$132K$240K
Gross Margin79%80%77%78%80%
EBITDA-($8M)($6M)($8M)($8M)
EBITDA Margin-(2771%)(5140%)(4587%)(2775%)
EBIT Margin(2655%)(2778%)(5143%)(4596%)(2782%)
Net Profit($8M)($8M)($5M)($8M)($8M)
Net Margin(2621%)(2723%)(4198%)(4509%)(2726%)

Financial data powered by Morningstar, Inc.

Nexalin Technology Stock Performance

Nexalin Technology has current market cap of $13M, and enterprise value of $10M.


Nexalin Technology's stock price is $0.60.

Nexalin Technology has an EPS (earnings per share) of $-0.38.

See more trading valuation data for Nexalin Technology
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$10M$13M9.7%---$-0.38

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nexalin Technology Valuation Multiples

Nexalin Technology trades at 32.2x EV/Revenue multiple, and (1.2x) EV/EBITDA.

See NTM and 2027E valuation multiples for Nexalin Technology

Nexalin Technology Financial Valuation Multiples

As of May 30, 2026, Nexalin Technology has market cap of $13M and EV of $10M.

Nexalin Technology has a P/E ratio of (1.6x).

LTMLast FY202320242025202620272028
EV/Revenue32.2x34.1x92.9x61.0x34.1x
EV/EBITDA-(1.2x)(1.8x)(1.3x)(1.2x)
EV/EBIT(1.2x)(1.2x)(1.8x)(1.3x)(1.2x)
EV/Gross Profit40.6x42.8x121.0x77.9x42.8x
P/E(1.6x)(1.6x)(2.8x)(1.7x)(1.6x)
EV/FCF-(2.0x)(2.6x)(2.5x)(2.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nexalin Technology Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Nexalin Technology Margins & Growth Rates

Nexalin Technology grew revenue by 14% and net profit by 5% in the last fiscal year.

In the most recent fiscal year, Nexalin Technology reported gross margin of 80%, EBITDA margin of (2771%), and net margin of (2723%).

See estimated margins and future growth rates for Nexalin Technology

Nexalin Technology Margins

Last FY202420252026202720282029
Gross Margin80%78%80%79%
EBITDA Margin(2771%)(4587%)(2775%)-
EBIT Margin(2778%)(4596%)(2782%)(2501%)
Net Margin(2723%)(4509%)(2726%)(2494%)
FCF Margin(1674%)(2439%)(1676%)-

Nexalin Technology Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth14%52%79%14%
Gross Profit Growth13%55%82%13%
EBITDA Growth-36%8%-
EBIT Growth3%36%8%3%
Net Profit Growth5%64%8%5%
FCF Growth-4%23%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Nexalin Technology Operational KPIs

Nexalin Technology's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.6M for the same period.

Access forward-looking KPIs for Nexalin Technology
LTMLast FY202320242025202620272028
Revenue per Employee-$0.0M---
Opex per Employee-$0.6M---
G&A Expenses to Revenue-2499%5220%3969%2502%
R&D Expenses to Revenue401%359%-706%359%
Opex to Revenue-2858%5220%4674%2861%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Nexalin Technology Competitors

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E

This data is available for Pro users. Sign up to see all Nexalin Technology competitors and their valuation data.

Start Free Trial

Nexalin Technology M&A Activity

Nexalin Technology has acquired 1 company to date.

Last acquisition by Nexalin Technology was on May 18th 2026. Nexalin Technology acquired PONM for $1M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Nexalin Technology

PONM
Description
PONM is a company that develops secure cloud and mobile software linking patients, clinicians, and therapeutic technologies.
HQ Country-
HQ City
-
Deal Date18 May 2026
Valuation$1M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Nexalin Technology acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nexalin Technology

When was Nexalin Technology founded?Nexalin Technology was founded in 2010.
Where is Nexalin Technology headquartered?Nexalin Technology is headquartered in United States.
How many employees does Nexalin Technology have?As of today, Nexalin Technology has over 14 employees.
Is Nexalin Technology publicly listed?Yes, Nexalin Technology is a public company listed on Nasdaq.
What is the stock symbol of Nexalin Technology?Nexalin Technology trades under NXL ticker.
When did Nexalin Technology go public?Nexalin Technology went public in 2022.
Who are competitors of Nexalin Technology?Nexalin Technology main competitors include
What is the current market cap of Nexalin Technology?Nexalin Technology's current market cap is $13M.
What is the current revenue of Nexalin Technology?Nexalin Technology's last 12 months revenue is $320K.
What is the current revenue growth of Nexalin Technology?Nexalin Technology revenue growth (NTM/LTM) is 52%.
What is the current EV/Revenue multiple of Nexalin Technology?Current revenue multiple of Nexalin Technology is 32.2x.
Is Nexalin Technology profitable?No, Nexalin Technology is not profitable.
What is the current net income of Nexalin Technology?Nexalin Technology's last 12 months net income is ($8M).
How many companies Nexalin Technology has acquired to date?As of May 2026, Nexalin Technology has acquired 1 company.
What was the largest acquisition by Nexalin Technology?$1M acquisition of PONM on 18th May 2026 was the largest M&A Nexalin Technology has done to date.
What companies Nexalin Technology acquired?Nexalin Technology acquired PONM.
In how many companies Nexalin Technology has invested to date?Nexalin Technology hasn't invested in any companies yet (or none have been disclosed publicly).

Lists including Nexalin Technology

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial